SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-004940
Filing Date
2023-02-28
Accepted
2023-02-28 17:09:07
Documents
1
Period of Report
2023-02-24

Document Format Files

Seq Description Document Type Size
1 230228 FORM 4 (YODER) rdgdoc.html 4  
1 230228 FORM 4 (YODER) rdgdoc.xml 4 3714
  Complete submission text file 0001437749-23-004940.txt   5222
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LISE-MEITNER-STRASSE 30 C/O PIERIS PHARMACEUTICALS, INC. FREISING-WEIHENSTEPHAN 2M 85354
Business Address
Yoder Stephen S. (Reporting) CIK: 0001645577 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 23687069